These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30804948)

  • 1. Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion.
    Rådestad E; Sundin M; Törlén J; Thunberg S; Önfelt B; Ljungman P; Watz E; Mattsson J; Uhlin M
    Front Immunol; 2019; 10():189. PubMed ID: 30804948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors.
    Rådestad E; Wikell H; Engström M; Watz E; Sundberg B; Thunberg S; Uzunel M; Mattsson J; Uhlin M
    J Immunol Res; 2014; 2014():578741. PubMed ID: 25371909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
    Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
    Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency.
    Li Pira G; Malaspina D; Girolami E; Biagini S; Cicchetti E; Conflitti G; Broglia M; Ceccarelli S; Lazzaro S; Pagliara D; Meschini A; Bertaina A; Montanari M; Locatelli F
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2056-2064. PubMed ID: 27519279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
    Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H
    Front Immunol; 2019; 10():1997. PubMed ID: 31507601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower incidence of grade II-IV acute Graft-versus-Host-Disease in pediatric patients recovering with high Vδ2+ T cells after allogeneic stem cell transplantation with unmanipulated bone marrow grafts: a prospective single-center cohort study.
    Müller T; Alasfar L; Preuß F; Zimmermann L; Streitz M; Hundsdörfer P; Eggert A; Schulte J; von Stackelberg A; Oevermann L
    Front Immunol; 2024; 15():1433785. PubMed ID: 39136029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of T and NK cells after haploidentical hematopoietic cell transplantation using αβ T cell-depleted grafts and the clinical implication of γδ T cells.
    Park M; Im HJ; Lee YJ; Park N; Jang S; Kwon SW; Park CJ; Choi ES; Koh KN; Seo JJ
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29090489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. αβ T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation without Antithymocyte Globulin in Children with Chemorefractory Acute Myelogenous Leukemia.
    Shelikhova L; Ilushina M; Shekhovtsova Z; Shasheleva D; Khismatullina R; Kurnikova E; Pershin D; Balashov D; Radygina S; Trakhtman P; Kalinina I; Muzalevskii Y; Kazachenok A; Zaharova V; Brilliantova V; Olshanskaya Y; Panferova A; Zerkalenkova E; Baidildina D; Novichkova G; Rumyantsev A; Maschan A; Maschan M
    Biol Blood Marrow Transplant; 2019 May; 25(5):e179-e182. PubMed ID: 30677509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells.
    Müller N; Landwehr K; Langeveld K; Stenzel J; Pouwels W; van der Hoorn MAWG; Seifried E; Bonig H
    Cytotherapy; 2018 Apr; 20(4):532-542. PubMed ID: 29500069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of alphabeta- and gammadelta-T cells in allogenic donor marrow on engraftment, chimerism, and graft-versus-host disease.
    Huang Y; Cramer DE; Ray MB; Chilton PM; Que X; Ildstad ST
    Transplantation; 2001 Dec; 72(12):1907-14. PubMed ID: 11773887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
    Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
    Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex Vivo CD34
    Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.
    Bleakley M; Heimfeld S; Loeb KR; Jones LA; Chaney C; Seropian S; Gooley TA; Sommermeyer F; Riddell SR; Shlomchik WD
    J Clin Invest; 2015 Jul; 125(7):2677-89. PubMed ID: 26053664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
    Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
    Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCR αβ+/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: a review of current data.
    Sahasrabudhe K; Otto M; Hematti P; Kenkre V
    Leuk Lymphoma; 2019 Mar; 60(3):598-609. PubMed ID: 30187806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using αβ
    Diaz MA; Zubicaray J; Molina B; Abad L; Castillo A; Sebastian E; Galvez E; Ruiz J; Vicario JL; Ramirez M; Sevilla J; González-Vicent M
    Front Immunol; 2019; 10():2504. PubMed ID: 31736949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
    Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
    Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of γδ T cells on clinical outcome of hematopoietic stem cell transplantation: systematic review and meta-analysis.
    Arruda LCM; Gaballa A; Uhlin M
    Blood Adv; 2019 Nov; 3(21):3436-3448. PubMed ID: 31714966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children.
    Kałwak K; Porwolik J; Mielcarek M; Gorczyńska E; Owoc-Lempach J; Ussowicz M; Dyla A; Musiał J; Paździor D; Turkiewicz D; Chybicka A
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1388-401. PubMed ID: 20382248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alemtuzumab-based T-cell depletion on graft compositional change in vitro and immune reconstitution early after allogeneic stem cell transplantation.
    Roex MCJ; Wijnands C; Veld SAJ; van Egmond E; Bogers L; Zwaginga JJ; Netelenbos T; von dem Borne PA; Veelken H; Halkes CJM; Falkenburg JHF; Jedema I
    Cytotherapy; 2021 Jan; 23(1):46-56. PubMed ID: 32948458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.